- Home
- PTGX vs NXE Comparison
PTGX vs NXE Comparison
Compare PTGX & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- NXE
- Stock Information
- Founded
- PTGX 2006
- NXE 2011
- Country
- PTGX United States
- NXE Canada
- Employees
- PTGX N/A
- NXE N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- NXE
- Sector
- PTGX Health Care
- NXE
- Exchange
- PTGX Nasdaq
- NXE Nasdaq
- Market Cap
- PTGX 3.7B
- NXE 3.9B
- IPO Year
- PTGX 2016
- NXE N/A
- Fundamental
- Price
- PTGX $61.69
- NXE $8.35
- Analyst Decision
- PTGX Strong Buy
- NXE
- Analyst Count
- PTGX 9
- NXE 0
- Target Price
- PTGX $70.44
- NXE N/A
- AVG Volume (30 Days)
- PTGX 925.0K
- NXE 7.9M
- Earning Date
- PTGX 11-06-2025
- NXE 11-07-2025
- Dividend Yield
- PTGX N/A
- NXE N/A
- EPS Growth
- PTGX N/A
- NXE N/A
- EPS
- PTGX 0.80
- NXE N/A
- Revenue
- PTGX $209,180,000.00
- NXE N/A
- Revenue This Year
- PTGX N/A
- NXE N/A
- Revenue Next Year
- PTGX $248.17
- NXE N/A
- P/E Ratio
- PTGX $73.55
- NXE N/A
- Revenue Growth
- PTGX N/A
- NXE N/A
- 52 Week Low
- PTGX $33.31
- NXE $3.91
- 52 Week High
- PTGX $61.89
- NXE $8.96
- Technical
- Relative Strength Index (RSI)
- PTGX 61.67
- NXE 63.09
- Support Level
- PTGX $57.90
- NXE $7.54
- Resistance Level
- PTGX $60.40
- NXE $8.49
- Average True Range (ATR)
- PTGX 2.47
- NXE 0.35
- MACD
- PTGX 0.06
- NXE 0.04
- Stochastic Oscillator
- PTGX 94.34
- NXE 84.29
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.